The Trump Administration Finalizes Rule to End Federal Support for Gender Affirming Care The Trump administration has finalized its rule to end federal support for gender affirming care through Medicaid and the Children's Health Insurance Program (CHIP).
This decision defies medical evidence and perpetuates a toxic cycle of stigma and marginalization that threatens the well being of vulnerable children. On paper, the rule appears driven by concerns over cost.
However, closer examination reveals that ideology masquerades as policy. The administration's claims about "evidence based care" are hollow when juxtaposed with their actions.